EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of a new fecal occult blood testing


Journal of Kyoto Prefectural University of Medicine 95(10): 1331-1338
Evaluation of a new fecal occult blood testing
The incidence of colorectal cancer is increasing in Japanese, and several trials for its early detection have been conducted. Fecal occult blood testing has been proved to be useful in the mass screening of colorectal cancer. New methods based on immunological reaction have recently been developed, which exclusively detect human hemoglobin in the stool. In this paper, we evaluated the usefulness of the new fecal occult blood testing (OC-Hemodia-Eiken), which is based on latex agglutination reaction, in the detection of colorectal cancer. Three days consecutive testing was carried out in 30 cases with colorectal cancer, 35 cases with colorectal polyp, 8 cases with gastric cancer and 137 normal subjects. Positive results were obtained in 100% of colorectal cancer, 42.9% of colorectal polyp and 37.5% of gastric cancer. False positive ratio in the normal subjects was low (5.1%). These data show that the new method is superior in both sensitivity and specificity to other immunological fecal occult blood tests using enzyme immunoassay. While other immunological tests are technically complicated, this new test is rather easy and time-sparing. Considering these advantages, OC-Hemodia-Eiken is expected to be useful in the mass screening of colorectal cancer.

(PDF 0-2 workdays service: $29.90)

Accession: 005395371



Related references

Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing. Zeitschrift für Arztliche Fortbildung 81(19): 1007-1009, 1987

Laboratory evaluation of products for fecal occult blood testing. Gastroenterology 78(5 PART 2): 1165, 1980

Evaluation of the OC-SENSOR neo system for testing fecal occult blood. Korean Journal of Laboratory Medicine 27(3): 210-215, 2007

An evaluation of fecal occult blood screening in automated multiphasic health testing and services. Japanese Journal of Clinical Oncology 17(2): 107-112, 1987

Evaluation of fecal occult blood testing in colon cancer screening using total colonoscopy as the criterion standard. Gastroenterology 102(4 PART 2): A380, 1992

Screening for colorectal cancer in clinical practice evaluation of fecal occult blood testing on 2 successive days. Journal of the Japan Society of Coloproctology 37(6): 699-705, 1984

Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiology, Biomarkers & Prevention 17(4): 799-804, 2008

Overall evaluation of an immunological latex agglutination system for fecal occult blood testing in the colorectal cancer screening program of Florence. International Journal of Biological Markers 27(3): E195-E202, 2013

Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test. Zeitschrift für Arztliche Fortbildung 81(20): 1057-1059, 1987

Chemical testing of occult blood in feces hematest occultest and guaiac testing correlated with chromium 51 estimation of fecal blood loss. Medical Journal Of Australia: 1291-1293, 1969